SUMOylation is a reversible post-translational modification essential for genome stability. Using high-resolution MS, we have studied global SUMOylation in human cells in a site-specific manner, identifying a total of >4,300 SUMOylation sites in >1,600 proteins. To our knowledge, this is the first time that >1,000 SUMOylation sites have been identified under standard growth conditions. We quantitatively studied SUMOylation dynamics in response to SUMO protease inhibition, proteasome inhibition and heat shock. Many SUMOylated lysines have previously been reported to be ubiquitinated, acetylated or methylated, thus indicating cross-talk between SUMO and other post-translational modifications. We identified 70 phosphorylation and four acetylation events in proximity to SUMOylation sites, and we provide evidence for acetylation-dependent SUMOylation of endogenous histone H3. SUMOylation regulates target proteins involved in all nuclear processes including transcription, DNA repair, chromatin remodeling, precursor-mRNA splicing and ribosome assembly.
Reversible post-translational modification (PTM) of lysine residues in proteins by small ubiquitin-like modifiers (SUMOs) has a key role in genome stability and transcription [1] [2] [3] . Important SUMO-target proteins in the DNA-damage response include PCNA 4, 5 , BRCA1 (ref. 6) and 53BP1 (ref. 7) . SUMOs are conjugated to target proteins via an enzymatic cascade involving a dimeric E1 enzyme (SAE1-SAE2), a single E2 enzyme (Ubc9) and a limited number of E3 enzymes 8 . Mice deficient in Ubc9 die at the early postimplantation stage as a result of chromosome-condensation and chromosome-segregation defects, thus underlining the essential role of SUMOylation in the maintenance of genome stability 9 .
Frequently, SUMOylation regulates the function of target proteins by enabling or stabilizing noncovalent protein-protein interactions via SUMO-interaction motifs (SIMs) 8 . Classical examples of this type of interaction include the binding of SUMOylated RanGAP1 to the nucleoporin RanBP2 (ref. 10 ) and the binding of the SRS2 helicase to SUMOylated PCNA 11, 12 .
Despite great interest in SUMOylation in the fields of genome stability, transcriptional regulation, nuclear organization and signal transduction as well as interest from a clinical point of view, insight into global protein SUMOylation is limited. MS-based proteomics has enabled global insight into different PTMs in a site-specific manner 13, 14 , including phosphorylation 15, 16 , acetylation 17 , methylation 18 , glycosylation 19 and ubiquitination [20] [21] [22] [23] [24] . Affinity-purification strategies include immunoprecipitation and TiO 2 -and Fe 3+ -immobilized metal affinity chromatography. Highly potent SUMO proteases 25 , inconvenient C-terminal tryptic SUMO tags and low stoichiometry combined with suboptimal purification methods have hampered the identification of SUMO-acceptor lysines in target proteins 14, [26] [27] [28] [29] .
Here, we set out to develop an efficient purification strategy to study global protein SUMOylation in a site-specific and dynamic manner.
RESULTS

A strategy for mapping SUMO sites in endogenous proteins
To facilitate the study of SUMOylated proteins, a common method involves the use of epitope-tagged SUMO to allow efficient purification after highly denaturing lysis of cells to inactivate SUMO proteases. We enriched SUMOylated peptides from a HeLa cell line stably expressing decahistidine (His 10 )-tagged SUMO-2. This tag is small and compatible with denaturing buffer conditions. We established these stable cells by using a bicistronic lentivirus encoding His 10 -SUMO-2 and GFP separated by an internal ribosome entry site (IRES). After infection, we used flow cytometry to obtain a population expressing this construct at low levels. We confirmed low expression levels by immunoblotting ( Fig. 1a) . As expected, the protein located predominantly in the nucleus (Fig. 1b) 30, 31 . The His 10 tag, in contrast to the hexahistidine tag commonly used in the field, enabled singleround purification with a high yield and purity (Fig. 1c) .
In order to enrich for SUMOylated peptides, we used a SUMO-2 form that is resistant to cleavage by endopeptidase Lys-C. Lysinedeficient (K0) SUMO-2 behaves very similarly to wild-type SUMO-2, except for SUMO polymerization 29 . Our purification strategy consisted of a first round of His 10 -SUMO-2 purification, a filter step to concentrate SUMO-2 conjugates while simultaneously separating SUMO-2 conjugates from free SUMO-2, a digestion by Lys-C and a second round of purification followed by a trypsin digest ( Fig. 1d,e) . The second round of purification enabled enrichment at the site level, greatly reducing the complexity of the final sample. r e s o u r c e The C-terminal tryptic fragment of wildtype human SUMO-2 is 32 amino acids (aa) and, owing to its size, is not compatible with efficient mapping of SUMO-2-acceptor lysines. In contrast, yeast SUMO, Smt3, contains a conveniently located arginine that results in a 5-aa C-terminal tryptic fragment. We have generated a SUMO-2 Q87R mutant mimicking yeast SUMO to enable the identification of SUMO-2-acceptor lysines by MS. SUMOylation is a dynamic process that is regulated via cross-talk with the ubiquitin-proteasome system 32, 33 and is sensitive to heat shock 30 and to the broad-range inhibitor of SUMO and ubiquitin proteases PR-619. Treatments with the proteasome inhibitor MG-132, heat shock and PR-619 resulted in considerable accumulation of SUMO-2 conjugates (Fig. 1f) .
Identification of 4,361 SUMO-2 sites in 1,606 proteins
We analyzed tryptic digests of in solution-digested repurified SUMOylated peptides by nanoscale LC-MS/MS, without further fractionation, with 2-h LC gradients. We identified 5,339 SUMOylated peptides corresponding to 4,361 unique SUMOylation sites ( Supplementary Table 1 ) in 1,606 proteins ( Supplementary  Table 2 ), at a false discovery rate (FDR) below 1%. Mass accuracy was within 3 p.p.m. for 98.0% of all identified sites and within 6 p.p.m. for all sites, with an average absolute mass error of 0.77 p.p.m. The majority of identified SUMOylation sites had an Andromeda peptide score in the range of 60-100 ( Fig. 2a) . We pinpointed the precise SUMO-2-acceptor lysines in over 98.8% of the SUMOylated peptides ( Supplementary Table 1 ). The overall purity achieved by our method was demonstrated by the average presence of a SUMO-2acceptor lysine in 25.0% of the peptides identified in the final purified fractions. For negative controls, we attempted identification of SUMOylated lysines after performing site enrichment on the parental HeLa cell line. In addition, we attempted to identify SUMO sites from HeLa total lysates. In both cases, we did not find a single site.
This methodology represents a step forward for the field because it enables efficient analysis of SUMOylation at a proteome-wide level in a site-specific manner and requires only a relatively small number of cells (~20 million). Moreover, unlike previously reported methodologies, it allows cells to be grown under standard conditions. Our data set includes an extensive number of well-known SUMO-target proteins-for example, RanGAP1, PML, topoisomerases 1, 2α and 2β, PCNA, BLM, BRCA1, RanBP2, RNF168 and SAFB2 (Supplementary Table 2 )-thus further confirming the validity of the approach.
In total, we identified 1,069 sites from cells grown under regular cellculture conditions (Fig. 2b,c) npg r e s o u r c e sites after heat shock, proteasome-inhibitor treatment and/or SUMO protease-inhibitor treatment, representing three quarters (75.5%) of the total identified sites (Fig. 2b) . The peak intensities of the SUMOylated peptides identified in response to MG-132, PR-619 or heat shock were higher compared to those in the control sample, thus indicating that not only the number of acceptor sites but also the stoichiometry of SUMOylation increased upon treatment ( Fig. 2d) .
We used label-free quantification (LFQ) to chart the changes in overall protein SUMOylation after the cellular treatments and found significant changes in the SUMOylation states of hundreds of proteins ( Supplementary Fig. 1a-c and Supplementary Table 3 ). In order to assess the reproducibility of the methodology, we performed principal component analysis (PCA) to visualize unbiased correlation between all replicate experiments ( Supplementary Fig. 1d ). We performed the control experiment in sextuplicate, the PR-619 experiment in quintuplicate and the MG-132 and heat-shock experiments in triplicate. Using PCA, we found that all same-condition replicates clustered closely together. Additionally, we performed scatter-plot analysis to assess Pearson correlation between all experiments ( Supplementary  Fig. 1e ). We found high correlation between same-condition samples at the protein level (R of 0.85-0.92) and at the site level (R of 0.66-0.75), as compared to correlation between different-condition (but nonetheless SUMO-enriched) samples. Finally, we performed hierarchical clustering of all replicates, which highlighted a strong reproducibility between same-condition replicates and identified clusters of proteins that are upregulated or downregulated in SUMOylation, depending on the various cellular stresses (Supplementary Fig. 1f ).
In order to confirm the biological validity of the lysine-deficient SUMO mutant for the purpose of mapping SUMO sites in the context of cellular stress conditions, we compared total SUMO pools in HeLa cells expressing either wild-type or the K0 mutant ( Supplementary  Fig. 2a ). We observed no notable differences in accumulation of SUMOylated protein pools in response to all stress conditions tested, regardless of whether we used wild-type or lysine-deficient SUMO. Furthermore, we found that the amount of copurifying ubiquitin was identical in both cell lines, showing that cross-talk between ubiquitination and SUMOylation is not visibly affected.
Further, we validated a set of newly identified SUMO-target proteins-RNF216, SNW1, TCF12 and ZND280D-through pulldown and immunoblot analysis with a cell line stably expressing His 10tagged SUMO-2 wild type ( Supplementary Fig. 2b) . Additionally, because we used the PR-619 inhibitor of SUMO protease in SUMO proteomics, which had not been previously reported to our knowledge, we were able to validate the quantified change in SUMOylation of various target proteins by using a wild-type SUMO cell line. This set includes four known SUMO targets (FOXM1, HNRNPM, RAD18 and SART1) as well as two new SUMO-target proteins (WDR70 and MCM10) ( Supplementary Fig. 2c ).
SUMOylation sites per protein ranged from a single site in nearly half of all SUMO-target proteins to ten or more sites in 96 proteins and 20 or more sites in 13 proteins: PARP1 (20 sites), ZMYM2 (20 sites), ZNF281 (21 sites), MECOM (22 sites), NSUN2 (22 sites), MKI67 (23 sites), MIS18BP1 (25 sites), TPX2 (26 sites), BLM (27 sites), NKTR (27 sites), FBN1 (31 sites), GTF2I (34 sites) and ZNF451 (40 sites) ( Fig. 2e ). We found that most proteins (64.2%) were conjugated to only one or two SUMO moieties.
We compared all SUMOylated proteins and sites identified in this study to those from previous studies on SUMOylation. On average, we identified 51% of previously reported MS/MS-identified SUMOtarget proteins ( Supplementary Fig. 3a and Supplementary Table 4 ) and expanded the known number of SUMOylated proteins by nearly 1,000. We found 52% of all previously reported MS/MS-identified SUMOylation sites ( Supplementary Fig. 3b ), as reported in the PhosphoSitePlus database (PSP; http://www.phosphosite.org/ 34 ) and more recently by Schimmel et al. 35 and Tammsalu et al. 36 . Our study expands the number of known MS/MS-identified SUMOylation sites by over 3,000, and we identified over 1,000 SUMOylation sites under standard growth conditions. SUMOylation is a key post-translational modification in all eukaryotes but is absent in prokaryotes. We studied phylogenetic conservation of SUMOylation with respect to conservation of entire proteomes (Supplementary Fig. 4a ). SUMOylated proteins are substantially more conserved than total proteomes. Within orthologs, SUMOylation is the most conserved post-translational modification, together with Phosphorylation position in relation to SUMO (aa) 1  0  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17 1 0 acetylation, which is equally conserved. In proteins with no orthologs in lower eukaryotes, SUMOylation is more conserved than phosphorylation but is less conserved than ubiquitination, acetylation and methylation ( Supplementary Fig. 4b) . This difference indicates an increased frequency of SUMOylation occurring on proteins that are absent in lower eukaryotes. We investigated the potential overlap between the identified SUMOacceptor lysines and other post-translational lysine modifications. For this purpose, we extracted all known human MS/MS-identified ubiquitination, acetylation and lysine-methylation sites from PSP and cross-compared modification sites (Fig. 3a,b and Supplementary  Table 5 ). SUMOylation is known to compete with ubiquitin for acceptor lysines in target proteins 37 . However, the extent of this cross-talk is currently unclear. We compared the identified SUMO-acceptor lysines to acceptor lysines for ubiquitin in the PSP database and found that nearly one-quarter (22.4%) of SUMOylation sites are also known to be ubiquitinated, thus indicating extensive cross-talk between SUMOylation and ubiquitination ( Fig. 3a,b) . Overlap between SUMOylation and acetylation and between SUMOylation and lysine methylation occurs less frequently, although this could be related to the smaller number of acetylation and methylation sites currently identified. From the perspective of all known ubiquitination, acetylation and methylation sites, SUMOylation occurs at roughly 4% of all these sites and does not favor one PTM over the other. Considering the observed amount of overlap between SUMO and other PTMs on the same lysines, as compared to the total lysines in the human proteome, the observed overlap is substantial.
Interestingly, cross-talk between SUMOylation and other post-translational modifications includes regulation of enzymatic components including 46 kinases, 33 proteins with intrinsic phosphatase activity, 29 ubiquitin protein ligase family members, 7 ubiquitin proteases, 7 acetyltransferases, 10 deacetylases, 22 methyltransferases and 13 demethylases ( Supplementary Table 6 ).
We found 23 peptides SUMOylated exclusively in conjunction with phosphorylation and an additional 47 peptides SUMOylated together with phosphorylation in a 'nonunique' fashion ( Supplementary Table 7 ). Phosphorylation occurred relatively close to the lysine and was present both upstream and downstream of the SUMOylation lysine. We found that phosphorylation occurred predominantly at or near to the +5 position ( Fig. 3c) , a result in agreement with the earlier described PDSM motif 29, 38 . We observed five phosphorylation sites at position +2 relative to the SUMOylated lysine; these sites, instead of glutamate or aspartate, could serve as the negative charge required for efficient SUMOylation.
Furthermore, we found direct modification of endogenous ubiquitin by SUMO-2 on Lys11, Lys48 and Lys63 under control conditions ( Fig. 3d) . After cellular treatments, we additionally observed SUMO-2 modification of ubiquitin on Lys6 and Lys27 (Fig. 3d) . Thus, mixed-chain formation between ubiquitin and ubiquitin-like family members is more extensive than was previously thought. Furthermore, we detected mixed-chain formation between all SUMO family members ( Supplementary Table 1 ).
We found three peptides SUMOylated exclusively in conjunction with acetylation, with two of these events occurring on histones Table 7 ). We detected an additional SUMOylated peptide from PML together with acetylation in a nonunique fashion. These sites could indicate acetylation-dependent SUMOylation, thus suggesting a new type of cross-talk between these two major modifications. In order to further investigate such a dependency, we treated HeLa cells expressing either wild-type or npg r e s o u r c e lysine-deficient SUMO with the histone deacetylase inhibitor trichostatin A (TSA), known for increasing acetylation of histones, or the histone acetyltransferase inhibitor curcumin, known for decreasing acetylation of histones 39 . Subsequently, we performed SUMO enrichment and investigated the SUMOylation state of histone H3 (Fig. 3f) .
To our knowledge, this is the first visualization of the modification of endogenous histone H3 by SUMO. Furthermore, we found that the SUMOylation of histone H3 increased upon TSA treatment, in correlation with an increase in histone H3 acetylation. Conversely, after treatment with curcumin SUMOylation of histone H3 decreased, in correlation with a decrease in histone H3 acetylation. The total pool of conjugated SUMO was mildly increased regardless of the inhibitors used, thus ruling out a nonspecific change in the SUMOylation state of histone H3 (Fig. 3f) . Our results demonstrate interplay between the acetylation and SUMOylation of endogenous histone H3.
Insight into the SUMOylation consensus motif
SUMOylation is known to occur on the classical consensus motif ΨKxE 40 or ΨKx(ED) 41 , where Ψ is a large hydrophobic amino acid.
Previously, we found that other residues are also used at the Ψ position 29 .
Our data set provides an opportunity to obtain further insight into the SUMOylation consensus motif. More than half of the identified sites from untreated cells matched the consensus motif KxE, whereas KxD-type sites were not enriched over background frequency (Fig. 4a) .
We studied the KxE-type SUMOylation motif in RanGAP1, a highly SUMOylated protein 10 (Supplementary Fig. 5a,b) . For a negative control, we included our previously described ∆GL RanGAP1 mutant 29 . The acidic residue is not necessarily located two positions downstream of the SUMOylated lysine; it can also be found two positions upstream, with aspartate occurring at a higher frequency at this position than at the regular SUMOylation motif (Fig. 4b) , in agreement with the inverted consensus motif EDxK that we proposed on the basis of a very small number of identified SUMOylation sites 29 . We confirmed the relevance of the Glu300 residue in the inverted motif covering Tel SUMOylated at Lys302 ( Supplementary  Fig. 5c,d) . Replacing this residue with alanine eliminated SUMOylation, whereas replacing it with aspartate did not completely abolish SUMOylation, a result in agreement with the inverted consensus motif (ED)xK.
We superimposed the 1,069 SUMOylation sites identified under control conditions, including a sequence window ranging from −15 to +15 aa, displaying the amino acid frequencies normalized to the randomly expected frequencies across the human proteome (Fig. 4a,c) . We observed the highest degree of enrichment for valine and isoleucine at −1, and glutamate at +2, with over half of all control SUMOylation sites adhering to this consensus. Among the top 50% and top 25% of the most abundant SUMOylation sites for glutamate at +2, this frequency increased to 60% and 67%, respectively, indicating that the lysines situated in SUMOylation consensus motifs are efficiently SUMOylated (Fig. 4d) . We observed a similar trend for the hydrophobic amino acids at −1 (Fig. 4e) . A further expanded consensus motif, taking statistical local enrichments into account, was (IVML)-K-(EQMTP)-E-P. Interestingly, the adherence to the consensus motif dropped moderately for sites mapped exclusively after heat-shock treatment and decreased drastically after MG-132 and PR-619 treatment, after which sites matching KxE reached as low as 13%, barely higher than the ubiquitin or random-lysine frequencies (Fig. 4d) . The 30-aa region flanking SUMOylated lysines was enriched with lysine and glutamate (Fig. 4a,c) . Thus, SUMOylated lysines are frequently located in regions that are enriched with charged residues and are therefore probably solvent exposed. Interestingly, SUMOylated regions are deficient in phenylalanine, tryptophan, tyrosine, leucine and, most notably, cysteine (Fig. 4a,c) . Because SUMOs are transferred along an enzymatic cascade via thioester formation, the reduced frequency of cysteines near SUMOylated lysines under standard conditions could help to prevent the formation of thioesters between SUMOs and target proteins. Interestingly, a reduced frequency of cysteine could also be observed for ubiquitinated regions, probably for the same reason as proposed for SUMOylation (Fig. 4f) . Reduced frequencies of cysteine were less pronounced for regions flanking methylated or acetylated lysines (Fig. 4f) .
Insight into SUMOylated protein groups
Protein domains that are frequently SUMOylated include the Krüppelassociated box (KRAB) domain, which is a repressor domain found in many zinc-finger protein-based transcription factors (Fig. 5a) . Other domains included zinc fingers, PHD fingers and RRM1, which all have important roles in binding of DNA, RNA or other proteins and are often found in nuclear or chromatin-associated proteins.
We investigated the subcellular localization of SUMOylated proteins by Gene Ontology (GO) cellular compartments classes and plotted all identified proteins and sites (Fig. 5b) . We found SUMOylation to be an almost exclusively nuclear modification, with cytoplasmic modification occurring primarily on proteins that are also annotated as nuclear. Enrichment analysis showed the highest ratio for chromatin-associated proteins, and this was closely followed by the ratio for nuclear proteins (Fig. 5b) . In contrast, cytoplasmic and membrane proteins were depleted. Correspondingly, the number of SUMO sites per protein was also higher in chromatin-associated and nuclear proteins.
The first identified SUMOylation site, Lys524 in the nuclearpore component RanGAP1, is located in an unstructured region of the protein 43 . SUMOylation is thought to occur predominantly in unstructured regions 41 . To investigate the localized structural properties of proteins around sites of SUMOylation, we folded all 4,361 sites in silico, including the 30-aa sequence window, as well as over 5,000 lysines randomly chosen from SUMOylated proteins as a reference set. We performed secondary-structure prediction of the modified lysine and classified the structures as α-helix, β-sheet or otherwise coiled (Fig. 5c) . Our results indicate a modest reduction in SUMOylation of α-helices and a significant increase in SUMOylation of β-sheets compared to background frequencies. This trend was most striking for KxE-type SUMOylation sites, where we observed a significant decrease in unstructured regions, as a trade-off for an increase in β-sheets. We additionally observed an increased tendency for SUMOylated regions to be solvent exposed (Fig. 5d) .
SUMO modifies highly interconnected networks of proteins
Genome stability, transcription and translation are three important biological processes as evidenced by term enrichment analysis for GO biological processes involving the identified SUMO targets (Fig. 5e) . Furthermore, nucleic acid metabolism, chromosome organization, DNA repair, cell-cycle regulation, RNA splicing, histone modification and nuclear-body organization are among the most enriched processes. For GO molecular functions, in absolute numbers, we identified 673 DNA-binding proteins and 484 zinc-binding proteins as the largest functional groups of SUMO-target proteins (Fig. 5f) . SUMO also substantially modified subunits from known complexes in the Comprehensive Resource of Mammalian Protein Complexes (CORUM) database, including Nop56p precursor rRNA, SIN2-SAP25, BRAF53-BRCA2, LARC, BHC, MeCP1 and HDAC1 and HDAC2 protein complexes (Fig. 5g) . Additional analyses by keywords and Kyoto Encyclopedia of Genes and Genomes (KEGG) terms also highlighted SUMO's regulation of many important cellular processes (Fig. 5h) , including an enrichment of proteins known to be involved in cancer pathways (Supplementary Table 8) , such as TP53, MITF, VHL, BRCA2, STAT1, FOS, JUN and SMAD4. The complete term enrichment analysis ( Supplementary Table 8 ) and a fully annotated list of all SUMOylated proteins ( Supplementary Table 9 ) are available online.
SUMOylated proteins form a very complex, highly organized network of interacting proteins, as we visualized with search tool for the retrieval of interacting genes and/or proteins (STRING) network analysis (Fig. 6a) . 60% of all identified proteins are part of one main functional cluster, at high STRING confidence. We performed STRING analyses on a per-treatment basis and at high STRING confidence to assess protein-protein-interaction enrichment ratios and network participation ( Table 1) . Overall, we observed ten times more interactions than expected, with the SUMO-target proteins from untreated cells and with multiple sites showing the highest degree of enrichment. The strength of the STRING networks, derived from interaction enrichment as well as participation of all proteins, was greatest for proteins identified under control conditions (Fig. 6b) . Strikingly, we observed proteins identified after heat shock and found that many proteins were significantly upregulated in SUMOylation after heat shock to form a highly coherent STRING network. This stands in contrast to proteins upregulated in SUMOylation after MG-132 or PR-619 treatments, which we found to be less related in their interactions.
Subsequently, we performed MCODE analysis, which revealed highly interconnected subclusters within the core network, including nine subclusters with interconnectivity scores ranging from 9 to 39 (Fig. 6a) . Three dominant clusters involve many functionally related proteins from the spliceosome and the ribosome as well as cell cycle-related factors (Fig. 6c) . Other clusters contain chromatinremodeling proteins, histone deacetylases, histone methyltransferases, regulators of mitotic prometaphase, regulators of ubiquitin protein Figure 6a corresponds to 'all'.
npg r e s o u r c e ligases and proteins involved in ribonucleoprotein-complex formation (Supplementary Fig. 7) . We found sites of SUMOylation, ubiquitination and acetylation to overlap substantially (Fig. 3a,b) . To further investigate this, we performed STRING analysis on the subset of proteins containing these lysines. We found that 70% of these proteins were situated in a single functional network (Supplementary Fig. 6a-c) . We found that, beyond the observed overlap between modification sites, these clusters of proteins were highly modified by SUMO, averaging over five SUMOylation sites per protein (Supplementary Fig. 6d) . Additionally, in these clusters as compared to the full SUMO network, we observed a higher degree of enrichment for protein-protein interactions than expected (Supplementary Fig. 6e ) and a much higher degree of network participation of all proteins. This resulted in some of the highest-scoring networks for proteins containing lysines modified by SUMO and either ubiquitin or acetyl groups, and by far the strongest network for proteins that are modified on the same lysines by all three of these major PTMs (Supplementary Fig. 6f) . Thus, SUMOylation appears to function in concert with other major PTMs, and it co-regulates a tight functional cluster of heavily modified and dynamic proteins.
DISCUSSION
We have developed a new methodology for identification of global SUMOylation sites, which enabled us to map over 4,300 SUMOacceptor lysines in over 1,600 proteins and has provided detailed insight into the function of SUMOylation. All nuclear processes are orchestrated by SUMOylation, including transcription, DNA repair, chromatin remodeling, precursor-mRNA splicing and ribosome assembly. Our data set represents an improvement over the relatively small number of SUMOylation sites that were found previously in cells cultured in standard growth conditions 29, 35 and provides a basis for the scientific community to perform follow-up studies. Our data set expands the number of known SUMOylation sites by over 3,000, reconfirms many of the 1,000 sites that were recently mapped in response to heat shock 36 and provides over 1,000 new sites identified under standard growth conditions. This is particularly relevant for the half of the identified sites that comprised sites not located in a SUMOylation consensus motif and that therefore have eluded in silico prediction. Furthermore, we have obtained new insight into the consensus motif for SUMOylation, finding that SUMOylation sites are frequently located in domains enriched in charged residues. Moreover, protein regions with SUMOylated lysines are deficient in cysteines, possibly to limit thioester formation between SUMOs and target proteins.
We also identified an unprecedented number of phosphorylation events occurring in proximity to SUMOylation, with 70 of these events almost matching the total number of SUMOylation sites mapped in our previously reported screen 29 . Moreover, the identification of four SUMO and acetyl comodified peptides, and of the acetylation-dependent modification of endogenous histone H3, suggests an interesting and new prospect for cross-talk between these two major PTMs in their regulation of nucleosomes. Previously, it was demonstrated that SUMOylation of histones is linked to transcriptional repression 44, 45 . In contrast, acetylation is associated with transcriptional activation. Acetylation-dependent SUMOylation of histone H3 is thus a surprising type of cross-talk with unclear significance. Hypothetically, these differences could be reconciled if histone H3 were to be first acetylated to activate transcription and later SUMOylated to generate a transient activation pattern. It would be interesting to study where acetylated and SUMOylated histone H3 is located on the genome.
Here, we compared SUMO-acceptor lysines to previously identified ubiquitin-acceptor lysines and acetylation and methylation sites 17, 24 . We found a substantial overlap between SUMO-acceptor lysines and ubiquitinated, acetylated and methylated lysines. It is known that SUMOylation and ubiquitination can occur consecutively 46 . Furthermore, we found that proteins containing lysines modified by SUMO and other PTMs contain twice as many SUMOylation sites on average and are much more likely to be functionally interacting. Additionally, our findings provide new insight into cross-talk between SUMOylation and ubiquitination. We found that five lysines in ubiquitin can be used as SUMO-acceptor lysines, thus indicating complex heterogeneous SUMO-ubiquitin chains and opening up exciting new avenues to investigate the mechanisms and biological relevance of this new type of signal transduction.
Our methodology, as well as that recently used by Tammsalu et al. 36 , still relies on the exogenous expression of a SUMO with a mutation inserted close to its C terminus. Such methodologies cannot identify lysines modified by endogenous and wild-type SUMO, such as those from animal tissues or patient material. Ultimately, the efficient and system-wide identification of SUMO-acceptor lysines in an entirely endogenous fashion remains a great challenge to be tackled. However, we have demonstrated that our methodology can accurately and reliably pinpoint SUMO-acceptor lysines. Furthermore, many other SUMOylation sites remain to be discovered as a result of cell typespecific SUMOylation or stimulus-dependent SUMOylation, both of which could reliably be investigated with the developed methodology.
METHODS
Methods and any associated references are available in the online version of the paper. Accession codes. MS proteomics RAW data have been deposited with the ProteomeXchange Consortium database via the Proteomics Identifications (PRIDE) partner repository 47 , under dataset ID PXD001061.
Note: Any Supplementary Information and Source Data files are available in the online version of the paper. dissociation (HCD) fragmentation. Separation of peptides was performed with 20-cm-long analytical columns (ID 75 µm, Polymicro Avantes) packed in house with 1.8 µm C18 beads (Reprospher 100), with a 120-min gradient from 5% to 75% acetonitrile in 0.1% formic acid and a flow rate of 250 nL/min. The mass spectrometer was operated in data-dependent acquisition mode with a top-ten method. Full-scan MS spectra were acquired with a target value of 3E6 and a resolution of 70,000, with a scan range from 300 to 1,750 m/z. HCD tandem MS/MS spectra were acquired with a target value of 1E5, a resolution of 17,500, and a normalized collision energy of 25%. All charges lower than two and higher than six were rejected, and all unknown charges were rejected. The underfill ratio was set to 0.1%, and a dynamic exclusion of 20 s was used. Alternatively, the underfill ratio was set to 1.0% with the dynamic exclusion time set to 10 s. Data processing. MaxQuant version 1.4.1.2 was used to analyze all RAW data 51, 52 . The control-condition experiment was performed in sextuplicate and measured as 11 technical replicates. The heat shock-experiment was performed in triplicate and measured as 6 technical replicates. The MG-132 experiment was performed in triplicate and measured as 6 technical replicates. The PR-619 experiment was performed in quintuplicate and measured as 9 technical replicates. MS/MS spectra were filtered and deisotoped, and the 15 most abundant fragments for each 100 m/z were retained. MS/MS spectra were filtered for a mass tolerance of 6 p.p.m. for precursor masses, and a mass tolerance of 20 p.p.m. was used for fragment ions. Peptide and protein identification was performed through matching the identified MS/MS spectra to a target-decoy version of the complete human UniProt database in addition to a database of commonly observed MS contaminants. Up to three missed tryptic cleavages were allowed. Cysteine carbamidomethylation was set as a fixed peptide modification. Protein N-terminal acetylation, peptide N-terminal carbamylation, methionine oxidation, QQTGG and pyro-QQTGG were set as variable peptide modifications. QQTGG was set as a lysine-specific modification, with a monoisotopic mass of 471.20776, and was not allowed to occur at the C-terminal end of peptides. Pyro-QQTGG may spontaneously form out of the tryptic QQTGG remnant as a result of cyclization of the N-terminal glutamine. Pyro-QQTGG (pQQTGG) was set as a lysinespecific modification, with a monoisotopic mass of 454.18121, and was not allowed to occur at the C-terminal ends of peptides. In order to increase identification confidence, diagnostic peaks were searched within MS/MS spectra corresponding to SUMOylated peptides. To this end, candidate MS/MS spectra were searched for peaks corresponding in m/z to fragmentation of the tryptic QQTGG or pQQTGG remnant present on all SUMOylated peptides. For QQTGG, b5-QQTGG, b4-QQTG, b3-QQT and b2-QQ were accepted as diagnostic peaks. For pQQTGG, b5-pQQTGG, b4-pQQTG, b3-pQQT and b2-pQQ were accepted as diagnostic peaks. In addition to the above variable modifications, lysine acetylation and serine-threonine-tyrosine phosphorylation were individually added as further variable modifications in separate searches. For protein identification, peptides with all above variable modifications were accepted, and protein identification by at least one single SUMO-modified unique peptide was performed. Peptides were accepted with a minimum length of 6 aa, a maximum size of 5 kDa, and a maximum charge of six. The processed data were filtered by posterior error probability (PEP) to achieve a protein false discovery rate (FDR) of below 1% and a peptide-spectrum match FDR of below 1%, and in addition a site decoy fraction of 1% was set. SUMO-site peptides were additionally filtered to have an Andromeda score of at least 40, a localization score of at least 40, a localization probability of at least 90%, and the presence of at least one diagnostic QQTGG or pyro-QQTGG fragment in the MS/MS spectrum.
Label-free quantification (LFQ). Label-free quantification was performed with MaxQuant LFQ. Quantification was performed over 17 replicate experiments, including 6 control, 3 heat shock, 3 MG-132 and 5 PR-619 replicates. The standard (not fast) LFQ algorithm was used with otherwise default settings (minimum ratio count of two, min. neighbors of three, average neighbors of six). Protein LFQ values were log 2 transformed for further processing. Proteins were filtered for the presence of at least two identifying peptides and at least one SUMOylated peptide. To ensure biological reproducibility, only proteins detected in at least three replicates in any of the four treatment conditions were retained. Subsequently, missing values were imputed with Perseus software, with a down shift of 1.8 (log 2 ) and a variance of 0.3 (log 2 ) below the lowest detectable value within each separate replicate. LFQ values were median averaged within all treatment conditions, and subsequently control-condition LFQ values were subtracted from heat-shock, MG-132 and PR-619 values to yield the final log 2 ratio.
Statistics. Statistical methods used in this manuscript are detailed in Supplementary Note.
